Björn Nodin

Research Engineer
More filtering options
  1. 2019
  2. Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Sebastian Lundgren, Fagerström-Vahman, H., Zhang, C., Ben-Dror, L., Mardinoglu, A., Uhlen, M., Björn Nodin & Karin Jirström, 2019 Jan 14, In : Biomarker research. 7, 1, 1.

    Research output: Contribution to journalArticle

  3. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases

    Halla Vidarsdottir, Tran, L., Björn Nodin, Karin Jirström, Maria Planck, Jönsson, P., Mattsson, J. S. M., Botling, J., Micke, P. & Hans Brunnström, 2019, In : Human Pathology. 84, p. 221-230 10 p.

    Research output: Contribution to journalArticle

  4. 2018
  5. Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort

    Cramer, D. W., Fichorova, R. N., Terry, K. L., Yamamoto, H., Vitonis, A. F., Ardanaz, E., Aune, D., Boeing, H., Brandstedt, J., Boutron-Ruault, M. C., Chirlaque, M. D., Dorronsoro, M., Dossus, L., Duell, E. J., Gram, I. T., Gunter, M., Hansen, L., Idahl, A., Johnson, T., Khaw, K. T. & 20 others, Krogh, V., Kvaskoff, M., Mattiello, A., Matullo, G., Merritt, M. A., Bjorn Nodin, Orfanos, P., Onland-Moret, N. C., Palli, D., Peppa, E., Quiros, J. R., Sanchez-Perez, M. J., Severi, G., Tjønneland, A., Travis, R. C., Trichopoulou, A., Tumino, R., Weiderpass, E., Fortner, R. T. & Kaaks, R., 2018 Jul 1, In : Cancer Epidemiology Biomarkers and Prevention. 27, 7, p. 790-804 15 p.

    Research output: Contribution to journalArticle

  6. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort

    Fortner, R. T., Schock, H., Le Cornet, C., Hüsing, A., Vitonis, A. F., Johnson, T. S., Fichorova, R. N., Fashemi, T., Yamamoto, H. S., Tjønneland, A., Hansen, L., Overvad, K., Boutron-Ruault, M. C., Kvaskoff, M., Severi, G., Boeing, H., Trichopoulou, A., Papatesta, E. M., La Vecchia, C., Palli, D. & 28 others, Sieri, S., Tumino, R., Sacerdote, C., Mattiello, A., Onland-Moret, N. C., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quirós, J. R., Duell, E. J., Sánchez, M. J., Navarro, C., Ardanaz, E., Larrañaga, N., Björn Nodin, Karin Jirström, Idahl, A., Lundin, E., Khaw, K. T., Travis, R. C., Gunter, M., Johansson, M., Dossus, L., Merritt, M. A., Riboli, E., Terry, K. L., Cramer, D. W. & Kaaks, R., 2018 Apr 1, In : International Journal of Cancer. 142, 7, p. 1355-1360 6 p.

    Research output: Contribution to journalArticle

  7. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer

    Wendel, U., Persson, N., Risinger, C., Eva Bengtsson, Björn Nodin, Lena Danielsson, Charlotte Welinder, Fredrikson, G. N., Bo Jansson & Blixt, O., 2018 Feb 1, In : PLoS ONE. 13, 2, e0191872.

    Research output: Contribution to journalArticle

  8. A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes

    SOFIE OLSSON HAU, Emelie Karnevi, Sebastian Lundgren, Li, B., Lynch, S., Jacob Elebro, Margareta Heby, Björn Nodin, Jakob Eberhard, Uhlen, M., Moran, B., Gallagher, W. M. & Karin Jirström, 2018 Feb 1, p. 305-305. 1 p.

    Research output: Contribution to conferencePoster

  9. MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer

    Christina Stene, Polistena, A., Gaber, A., Björn Nodin, Ottochian, B., Adawi, D., Avenia, N., Karin Jirström & Louis Banka Johnson, 2018 Jan 1, In : In Vivo. 32, 1, p. 133-138 6 p.

    Research output: Contribution to journalArticle

  10. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases

    Halla Vidarsdottir, Tran, L., Björn Nodin, Karin Jirström, Maria Planck, Mattsson, J. S. M., Botling, J., Micke, P., Jönsson, P. & Hans Brunnström, 2018, In : American Journal of Clinical Pathology. 150, 6, p. 533-544 12 p.

    Research output: Contribution to journalArticle

  11. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification

    Emelie Karnevi, Dror, L. B., Mardinoglu, A., Jacob Elebro, Margareta Heby, Olofsson, S. E., Björn Nodin, Jakob Eberhard, Gallagher, W., Uhlén, M. & Karin Jirström, 2018, In : Oncotarget. 9, 5, p. 6188-6200 13 p.

    Research output: Contribution to journalArticle

  12. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

    Kaaks, R., Fortner, R. T., Hüsing, A., Barrdahl, M., Hopper, M., Johnson, T., Tjønneland, A., Hansen, L., Overvad, K., Fournier, A., Boutron-Ruault, M. C., Kvaskoff, M., Dossus, L., Johansson, M., Boeing, H., Trichopoulou, A., Benetou, V., La Vecchia, C., Sieri, S., Mattiello, A. & 22 others, Palli, D., Tumino, R., Matullo, G., Onland-Moret, N. C., Gram, I. T., Weiderpass, E., Sánchez, M. J., Navarro Sanchez, C., Duell, E. J., Ardanaz, E., Larranaga, N., Lundin, E., Idahl, A., Karin Jirström, Björn Nodin, Travis, R. C., Riboli, E., Merritt, M., Aune, D., Terry, K., Cramer, D. W. & Anderson, K. S., 2018, In : International Journal of Cancer. 143, 3, p. 515-526

    Research output: Contribution to journalArticle

  13. 2017
  14. Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups

    Emma Niméus, Elin Folkesson, Björn Nodin, Linda Hartman & Klintman, M., 2017 Dec 1, In : Anticancer research. 37, 12, p. 6845-6853 9 p.

    Research output: Contribution to journalArticle

  15. Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker

    Corvigno, S., Frödin, M., Wisman, G. B. A., Nijman, H. W., Van der Zee, A. GJ., Karin Jirström, Björn Nodin, Hrynchyk, I., Edler, D., Ragnhammar, P., Martin Johansson, Dahlstrand, H., Mezheyeuski, A. & Östman, A., 2017 Jun 13, In : The Journal of Pathology: Clinical Research. 3, 3, p. 214-224 11 p.

    Research output: Contribution to journalArticle

  16. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

    Wouters, J., Vizoso, M., Martinez-Cardus, A., Carmona, F. J., Govaere, O., Laguna, T., Joseph, J., Dynoodt, P., Aura, C., Foth, M., Cloots, R., van den Hurk, K., Balint, B., Murphy, I. G., McDermott, E. W., Sheahan, K., Jirström, K., Nodin, B., Mallya-Udupi, G., Van den Oord, J. J. & 2 others, Gallagher, W. M. & Esteller, M., 2017 Jun 5, In : BMC Medicine. 15, 1, p. 1-16 101.

    Research output: Contribution to journalArticle

  17. Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

    Fortner, R. T., Vitonis, A. F., Schock, H., Hüsing, A., Johnson, T., Fichorova, R. N., Fashemi, T., Yamamoto, H. S., Tjønneland, A., Hansen, L., Overvad, K., Boutron-Ruault, M-C., Kvaskoff, M., Severi, G., Boeing, H., Trichopoulou, A., Benetou, V., Vecchia, C. L., Palli, D., Sieri, S. & 27 others, Tumino, R., Matullo, G., Mattiello, A., Onland-Moret, N. C., Peeters, P. H., Weiderpass, E., Gram, I. T., Jareid, M., Quirós, J. R., Duell, E. J., Sánchez, M. J., Chirlaque, M-D., Ardanaz, E., Larrañaga, N., Björn Nodin, Jenny Brändstedt, Idahl, A., Khaw, K-T., Allen, N., Gunter, M., Johansson, M., Dossus, L., Merritt, M. A., Riboli, E., Cramer, D. W., Kaaks, R. & Terry, K. L., 2017 Mar 20, In : Journal of Ovarian Research. 10, 1, p. 1-14 14 p., 20.

    Research output: Contribution to journalArticle

  18. 2016
  19. The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.

    Micke, P., Mattsson, J. S. M., Djureinovic, D., Björn Nodin, Karin Jirström, Tran, L., Jönsson, P., Maria Planck, Botling, J. & Hans Brunnström, 2016 Jun, In : Journal of Thoracic Oncology. 11, 6, p. 862-872

    Research output: Contribution to journalArticle

  20. 2015
  21. Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome.

    Hedström, E., Pederiva, C., Farnebo, J., Björn Nodin, Karin Jirström, Brennan, D. J. & Farnebo, M., 2015, In : Cell Death & Disease. 6, e1892.

    Research output: Contribution to journalArticle

  22. The prognostic factors and multiple biomarkers in young patients with colorectal cancer.

    Wang, M-J., Ping, J., Li, Y., Adell, G., Arbman, G., Björn Nodin, Meng, W-J., Zhang, H., Yu, Y-Y., Wang, C., Yang, L., Zhou, Z-G. & Sun, X-F., 2015, In : Scientific Reports. 5, 10645.

    Research output: Contribution to journalArticle

  23. 2014
  24. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.

    Charlotta Hedner, Gaber, A., Korkocic, D., Björn Nodin, Uhlén, M., Kuteeva, E., Johannesson, H., Karin Jirström & Jakob Eberhard, 2014, In : Virchows Archiv: an international journal of pathology. 465, 6, p. 649-659

    Research output: Contribution to journalArticle

  25. 2013
  26. Immunohistochemical and molecular studies on ovarian cancer progression and prognosis

    Björn Nodin, 2013, Pathology, Lund University. 140 p.

    Research output: ThesisDoctoral Thesis (compilation)

  27. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

    Karolina Boman, Anna H Larsson, Segersten, U., Kuteeva, E., Johannesson, H., Björn Nodin, Jakob Eberhard, Uhlén, M., Malmström, P-U. & Karin Jirström, 2013, In : British Journal of Cancer. 108, 11, p. 2321-2328

    Research output: Contribution to journalArticle

  28. Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study

    Wangefjord, S., Sundström, M., Zendehrokh, N., Ericson Lindquist, K., Björn Nodin, Karin Jirström & Jakob Eberhard, 2013, In : Biology of Sex Differences. 4, 17.

    Research output: Contribution to journalArticle

  29. 2012
  30. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

    Jakob Eberhard, Gaber, A., Wangefjord, S., Björn Nodin, Uhlén, M., Ericson Lindquist, K. & Karin Jirström, 2012 Feb 28, In : British Journal of Cancer. 106, 5, p. 931-938 8 p.

    Research output: Contribution to journalArticle

  31. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer

    Björn Nodin, Johannesson, H., Wangefjord, S., O'Connor, D. P., Ericson Lindquist, K., Uhlen, M., Karin Jirström & Jakob Eberhard, 2012, In : Diagnostic Pathology. 7, 115

    Research output: Contribution to journalArticle

  32. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

    Anna H Larsson, Fridberg, M., Gaber, A., Björn Nodin, Levéen, P., Göran B Jönsson, Uhlen, M., Birgisson, H. & Karin Jirström, 2012, In : BMC Cancer. 12

    Research output: Contribution to journalArticle

  33. 2011
  34. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

    Hjelm, B., Brennan, D. J., Zendehrokh, N., Jakob Eberhard, Björn Nodin, Gaber, A., Ponten, F., Johannesson, H., Smaragdi, K., Frantz, C., Hober, S., Louis Banka Johnson, Sven Påhlman, Karin Jirström & Uhlen, M., 2011, In : Proteomics Clinical Applications. 5, 11-12, p. 624-635

    Research output: Contribution to journalArticle